EUVIMEDEUVIMED entdecken
Crossref

Management of cervical cancer with lymph nodes involvement in a large tertiary centre: Results from the preimmunotherapy era

Grégoire Laurent Delanghe, Alexandre Escande, Séverine Risbourg, Diane Sayadi, Alexandra Noeuvéglise, Aïcha Ben Miled, Camille Pasquesoone, Hortense Chevalier, Carlos Martinez-Gomez, Lucie Bresson, Anne-Sophie Navarro, Romain Cayez und 4 weitere

Cancer/Radiothérapie · 2026

DOI: 10.1016/j.canrad.2026.104875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer/Radiothérapie, 2026. Verfasst von Grégoire Laurent Delanghe und 15 weiteren Autor:innen. Beteiligte Einrichtung: University department of radiation oncology, centre de lutte contre le cancer Oscar-Lambret, Lille, France. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Lymphatic Metastasis, Brachytherapy, Chemoradiotherapy. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to assess the specific outcomes of patients locally advanced node-positive cervical cancer according to the International Federation of Gynaecology and Obstetrics receiving concurrent chemoradiotherapy and image-guided adaptive brachytherapy before adjuvant immunotherapy. PATIENTS AND METHODS: A cohort of 388 women with non-metastatic advanced cervical cancer and lymph node involvement treated at a single tertiary centre (2016-2021) was analysed. All patients underwent chemoradiotherapy followed by brachytherapy. Disease-free survival and overall survival were compared between patients with only pelvic node involvement (n=175) and those with at least para-aortic node involvement (n=213), as well as across node staging methods. Notably, some patients also had bladder or rectal involvement. RESULTS: With a median follow-up of 54.8 months, 152 progressions or recurrences were reported, including metastatic event in 99 cases (65.1 % of first events). Additionally, 22 deaths occurred without previous progression/relapse. This resulted in a 5-year disease-free survival rate of 50.8 % (95 % confidence interval [CI]: 45.2-56.2 %) for the entire cohort, significantly differing between the pelvic (58.5 %; 95 % CI: 50.1-65.9 %) and para-aortic (44.2 %; 95 % CI: 36.7-51.4 %) groups (p=0.007). The 5-year overall survival rate was 61.0 % (95 % CI: 55.7-65.8 %) in the entire cohort and was poorer in patients with para-aortic involvement (52.5 %; 95 % CI: 45.1-59.3 %; p=0.002). A larger high-risk clinical target volume at least 43.5cm3 (p=0.0001), para-aortic node involvement (p=0.01), and a total treatment duration of more than 55 days (p=0.01) were associated with a higher recurrence risk. CONCLUSION: Chemoradiotherapy followed by brachytherapy is effective and feasible for patients with node-positive cervical cancer. However, two-thirds of progressions or recurrences involved a distant event, suggesting the need to evaluate incremental systemic treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsLymphatic MetastasisBrachytherapyChemoradiotherapyHumansFemaleMiddle AgedTertiary Care CentersAdultAgedDisease-Free SurvivalNeoplasm StagingNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedRetrospective StudiesImmunotherapyAged, 80 and over

Stichwörter der Autor:innen

BrachytherapyCervical cancerNode involvement

Autor:innen und Institutionen

  • University department of radiation oncology, centre de lutte contre le cancer Oscar-Lambret, Lille, France.
  • Department of Radiation Oncology, centre Léonard-de-Vinci, Dechy, France.
  • Methodology and Biostatistics Unit, centre de lutte contre le cancer Oscar-Lambret, Lille, France.
  • University department of Medical Imaging, centre de lutte contre le cancer Oscar-Lambret, Lille, France.
  • Morphological and Molecular Pathology Unit, centre de lutte contre le cancer Oscar-Lambret, Lille, France.
  • University department of Gynaecological Medical Oncology, centre de lutte contre le cancer Oscar-Lambret, Lille, France.

Zitieren

APA

Laurent Delanghe, G., Escande, A., Risbourg, S., Sayadi, D., Noeuvéglise, A., Ben Miled, A., Pasquesoone, C., Chevalier, H., Martinez-Gomez, C., Bresson, L., Navarro, A. S., Cayez, R., Le Deley, M. C., Narducci, F., Lartigau, É. F., & Cordoba, A. (2026). Management of cervical cancer with lymph nodes involvement in a large tertiary centre: Results from the preimmunotherapy era. Cancer/Radiothérapie. https://doi.org/10.1016/j.canrad.2026.104875

Vancouver

Laurent Delanghe G, Escande A, Risbourg S, Sayadi D, Noeuvéglise A, Ben Miled A, et al. Management of cervical cancer with lymph nodes involvement in a large tertiary centre: Results from the preimmunotherapy era. Cancer/Radiothérapie. 2026. doi:10.1016/j.canrad.2026.104875

BibTeX
@article{LaurentDelanghe2026,
  author = {Laurent Delanghe, Grégoire and Escande, Alexandre and Risbourg, Séverine and Sayadi, Diane and Noeuvéglise, Alexandra and Ben Miled, Aïcha and Pasquesoone, Camille and Chevalier, Hortense and Martinez-Gomez, Carlos and Bresson, Lucie and Navarro, Anne-Sophie and Cayez, Romain and Le Deley, Marie-Cécile and Narducci, Fabrice and Lartigau, Éric F and Cordoba, Abel},
  title = {Management of cervical cancer with lymph nodes involvement in a large tertiary centre: Results from the preimmunotherapy era},
  journal = {Cancer/Radiothérapie},
  year = {2026},
  doi = {10.1016/j.canrad.2026.104875}
}
Kostenlos starten →